ReviewBiomaterials2022
In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications.
Kun Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it
ReviewBiomaterials2022
Kun Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.